US 12,421,232 B2
Kinase inhibitor compounds and compositions and methods of use
Kunal Kumar, New York, NY (US); Peng Wang, New York, NY (US); Roberto Sanchez, New York, NY (US); Adolfo Garcia-Ocaña, New York, NY (US); Andrew Stewart, New York, NY (US); and Robert Devita, New York, NY (US)
Assigned to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, New York, NY (US)
Filed by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, New York, NY (US)
Filed on Nov. 28, 2023, as Appl. No. 18/521,801.
Application 18/521,801 is a continuation of application No. 16/981,742, granted, now 11,866,427, previously published as PCT/US2019/023206, filed on Mar. 20, 2019.
Claims priority of provisional application 62/645,560, filed on Mar. 20, 2018.
Prior Publication US 2024/0132494 A1, Apr. 25, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/437 (2006.01); A61K 45/06 (2006.01); C07D 471/04 (2006.01)
CPC C07D 471/04 (2013.01) [A61K 31/437 (2013.01); A61K 45/06 (2013.01)] 19 Claims
 
1. A compound selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry